UK markets closed

Heidelberg Pharma AG (0QW5.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
2.9900-0.1100 (-3.55%)
At close: 11:09AM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.31
52-week change 3-34.05%
S&P500 52-week change 321.23%
52-week high 34.6700
52-week low 30.0000
50-day moving average 33.3732
200-day moving average 33.5207

Share statistics

Avg vol (3-month) 317
Avg vol (10-day) 319
Shares outstanding 528.13M
Implied shares outstanding 6N/A
Float 85.88M
% held by insiders 183.06%
% held by institutions 11.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21.046408:1
Last split date 307 Nov 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Nov 2023
Most-recent quarter (mrq)30 Nov 2023

Profitability

Profit margin -206.38%
Operating margin (ttm)-130.18%

Management effectiveness

Return on assets (ttm)-20.14%
Return on equity (ttm)-35.08%

Income statement

Revenue (ttm)9.86M
Revenue per share (ttm)0.21
Quarterly revenue growth (yoy)14.40%
Gross profit (ttm)N/A
EBITDA -26.84M
Net income avi to common (ttm)-20.35M
Diluted EPS (ttm)-0.8140
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)43.44M
Total cash per share (mrq)0.93
Total debt (mrq)5.83M
Total debt/equity (mrq)11.82%
Current ratio (mrq)2.86
Book value per share (mrq)1.06

Cash flow statement

Operating cash flow (ttm)-33.67M
Levered free cash flow (ttm)-21.5M